Chen et al., 2023 - Google Patents
Type I Photosensitizer Targeting G‐Quadruplex RNA Elicits Augmented Immunity for Cancer AblationChen et al., 2023
- Document ID
- 14965451139105417202
- Author
- Chen W
- Zhang Y
- Yi H
- Wang F
- Chu X
- Jiang J
- Publication year
- Publication venue
- Angewandte Chemie
External Links
Snippet
Type I photodynamic therapy (PDT) represents a promising treatment modality for tumors with intrinsic hypoxia. However, type I photosensitizers (PSs), especially ones with near infrared (NIR) absorption, are limited and their efficacy needs improvement via new targeting …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Type I Photosensitizer Targeting G‐Quadruplex RNA Elicits Augmented Immunity for Cancer Ablation | |
| Liu et al. | A smart theranostic prodrug system activated by reactive oxygen species for regional chemotherapy of metastatic cancer | |
| Yao et al. | The concept and examples of type-III photosensitizers for cancer photodynamic therapy | |
| Deng et al. | A photocaged, water-oxidizing, and nucleolus-targeted Pt (IV) complex with a distinct anticancer mechanism | |
| Shi et al. | Light‐induced self‐escape of spherical nucleic acid from endo/lysosome for efficient non‐cationic gene delivery | |
| Gong et al. | A smart theranostic nanocapsule for spatiotemporally programmable photo‐gene therapy | |
| Zeng et al. | Activation of pyroptosis by specific organelle-targeting photodynamic therapy to amplify immunogenic cell death for anti-tumor immunotherapy | |
| Fan et al. | Modulation of intracellular oxygen pressure by dual‐drug nanoparticles to enhance photodynamic therapy | |
| He et al. | Glutathione‐activatable and O2/Mn2+‐evolving nanocomposite for highly efficient and selective photodynamic and gene‐silencing dual therapy | |
| Wang et al. | Photosensitizer–gold nanorod composite for targeted multimodal therapy | |
| Feng et al. | Versatile Prodrug Nanoparticles for Acid‐Triggered Precise Imaging and Organelle‐Specific Combination Cancer Therapy | |
| Ferino et al. | Photodynamic therapy for ras-driven cancers: Targeting G-quadruplex RNA structures with bifunctional alkyl-modified porphyrins | |
| Zhang et al. | Copper‐Bacteriochlorin Nanosheet as a Specific Pyroptosis Inducer for Robust Tumor Immunotherapy | |
| Liu et al. | Nanoassemblies with effective serum tolerance capability achieving robust gene silencing efficacy for breast cancer gene therapy | |
| Zhao et al. | Oxygen nanocarrier for combined cancer therapy: oxygen‐boosted ATP‐responsive chemotherapy with amplified ROS lethality | |
| Sun et al. | Hydrogen sulfide gas amplified ROS cascade: FeS@ GOx hybrid nanozyme designed for boosting tumor chemodynamic immunotherapy | |
| Shi et al. | Reversing multidrug resistance by inducing mitochondrial dysfunction for enhanced chemo-photodynamic therapy in tumor | |
| Jiang et al. | Corrole‐based photodynamic antitumor therapy | |
| Wang et al. | Conjugated Polymers with Aggregation‐Induced Emission Characteristics for Fluorescence Imaging and Photodynamic Therapy | |
| Wang et al. | Self-adaptive nanoassembly enabling turn-on hypoxia illumination and periphery/center closed-loop tumor eradication | |
| Zhang et al. | Intelligent Nanodelivery System‐Generated 1O2 Mediates Tumor Vessel Normalization by Activating Endothelial TRPV4‐eNOS Signaling | |
| Cui et al. | DNA‐based pH‐responsive core–shell drug nanocarrier for tumor‐targeted chemo‐photodynamic therapy | |
| Zhao et al. | Carrier-free nano-PROTACs to amplify photodynamic therapy induced DNA damage through BRD4 degradation | |
| Wang et al. | CDK4/6 nano-PROTAC enhances mitochondria-dependent photodynamic therapy and anti-tumor immunity | |
| Agarwal et al. | Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression |